<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immunology Product Guide &#187; neutralizing antibodies</title>
	<atom:link href="http://www.immunologyproductguide.com/blog/tag/neutralizing-antibodies/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.immunologyproductguide.com/blog</link>
	<description>A comprehensive guide to immunology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 10:09:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Cervarix provides longest duration of neutralizing antibodies level against cervical cancer</title>
		<link>http://www.immunologyproductguide.com/blog/2008/05/15/cervarix-provides-longest-duration-of-neutralizing-antibodies-level-against-cervical-cancer/</link>
		<comments>http://www.immunologyproductguide.com/blog/2008/05/15/cervarix-provides-longest-duration-of-neutralizing-antibodies-level-against-cervical-cancer/#comments</comments>
		<pubDate>Thu, 15 May 2008 16:20:48 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Antibodies]]></category>
		<category><![CDATA[Vaccination]]></category>
		<category><![CDATA[CERVARIX]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[cervical cancer vaccine]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[neutralizing antibodies]]></category>

		<guid isPermaLink="false">http://www.immunologyproductguide.com/blog/2008/05/15/cervarix-provides-longest-duration-of-neutralizing-antibodies-level-against-cervical-cancer/</guid>
		<description><![CDATA[New data from an extended follow-up study show that GlaxoSmithKline PLC.’s cervical cancer candidate vaccine, Cervarix, generates sustained high levels of neutralizing antibodies against the two most common cervical cancer-causing virus types for up to 6.4 years. This is the longest duration of sustained neutralising antibody levels reported against both virus types HPV 16 and [...]]]></description>
			<content:encoded><![CDATA[<p><img vspace="5" align="right" width="200" src="http://www.immunologyproductguide.com/blog/wp-content/uploads/2008/05/gsk.png" hspace="5" alt="Glaxo" height="71" />New data from an extended follow-up study show that <a href="http://www.gsk.com/">GlaxoSmithKline PLC.</a>’s cervical cancer candidate vaccine, Cervarix, generates sustained high levels of neutralizing antibodies against the two most common cervical cancer-causing virus types for up to 6.4 years. This is the longest duration of sustained neutralising antibody levels reported against both virus types HPV 16 and 18 with a cervical cancer vaccine to date. Experts believe that neutralizing antibodies are essential for protection against cervical cancer.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.immunologyproductguide.com/blog/2008/05/15/cervarix-provides-longest-duration-of-neutralizing-antibodies-level-against-cervical-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
